Structure

Physi-Chem Properties

Molecular Weight:  522.26
Volume:  548.31
LogP:  4.464
LogD:  3.588
LogS:  -4.66
# Rotatable Bonds:  8
TPSA:  106.2
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.358
Synthetic Accessibility Score:  4.95
Fsp3:  0.484
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.85
MDCK Permeability:  1.9251679987064563e-05
Pgp-inhibitor:  0.974
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.599
30% Bioavailability (F30%):  0.819

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.342
Plasma Protein Binding (PPB):  98.9607162475586%
Volume Distribution (VD):  1.434
Pgp-substrate:  5.443643569946289%

ADMET: Metabolism

CYP1A2-inhibitor:  0.452
CYP1A2-substrate:  0.129
CYP2C19-inhibitor:  0.775
CYP2C19-substrate:  0.117
CYP2C9-inhibitor:  0.659
CYP2C9-substrate:  0.941
CYP2D6-inhibitor:  0.947
CYP2D6-substrate:  0.209
CYP3A4-inhibitor:  0.894
CYP3A4-substrate:  0.346

ADMET: Excretion

Clearance (CL):  9.471
Half-life (T1/2):  0.484

ADMET: Toxicity

hERG Blockers:  0.192
Human Hepatotoxicity (H-HT):  0.2
Drug-inuced Liver Injury (DILI):  0.643
AMES Toxicity:  0.005
Rat Oral Acute Toxicity:  0.163
Maximum Recommended Daily Dose:  0.012
Skin Sensitization:  0.608
Carcinogencity:  0.173
Eye Corrosion:  0.003
Eye Irritation:  0.064
Respiratory Toxicity:  0.165

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472545

Natural Product ID:  NPC472545
Common Name*:   WZRBVWLPCKNBQX-HSUYODJOSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  WZRBVWLPCKNBQX-HSUYODJOSA-N
Standard InCHI:  InChI=1S/C31H38O7/c1-19(2)27(33)38-26-25(37-28(34)22-12-8-7-9-13-22)30(5)20(3)11-10-14-23(30)29(4,31(26,6)35)16-15-21-17-24(32)36-18-21/h7-9,11-13,15-17,19,23,25-26,35H,10,14,18H2,1-6H3/b16-15+/t23-,25+,26+,29-,30+,31+/m1/s1
SMILES:  O=C1OCC(=C1)/C=C/[C@]1(C)[C@H]2CCC=C([C@]2(C)[C@H]([C@@H]([C@]1(C)O)OC(=O)C(C)C)OC(=O)c1ccccc1)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3577073
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. whole plant n.a. PMID[16755060]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. aerial part n.a. PMID[17666848]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. aerial part n.a. PMID[18239311]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19785430]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19962306]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[20078074]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota whole plants Nanning District, Guangxi Province, China 2012-Sep PMID[25647077]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota aerial parts Seoul, Korea n.a. PMID[26331882]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified Ratio CC50/EC50 = 5.4 n.a. PMID[456050]
NPT27 Others Unspecified CC50 = 49700.0 nM PMID[456050]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 EC50 = 9200.0 nM PMID[456050]
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition > 50.0 % PMID[456050]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472545 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC472551
0.9922 High Similarity NPC39549
0.9771 High Similarity NPC472547
0.9697 High Similarity NPC224491
0.9624 High Similarity NPC472546
0.9474 High Similarity NPC97667
0.9474 High Similarity NPC171207
0.9474 High Similarity NPC100913
0.9474 High Similarity NPC275592
0.9407 High Similarity NPC91703
0.9403 High Similarity NPC87448
0.9403 High Similarity NPC97947
0.9403 High Similarity NPC16912
0.9403 High Similarity NPC291599
0.9403 High Similarity NPC118080
0.9403 High Similarity NPC27377
0.9403 High Similarity NPC472576
0.9403 High Similarity NPC41481
0.9333 High Similarity NPC34012
0.9328 High Similarity NPC90614
0.927 High Similarity NPC472556
0.9242 High Similarity NPC474608
0.9203 High Similarity NPC474935
0.9197 High Similarity NPC125106
0.9197 High Similarity NPC188865
0.9197 High Similarity NPC38696
0.9197 High Similarity NPC475122
0.9197 High Similarity NPC472569
0.9197 High Similarity NPC11685
0.9197 High Similarity NPC163719
0.9197 High Similarity NPC476974
0.9197 High Similarity NPC241951
0.9197 High Similarity NPC57628
0.9197 High Similarity NPC470152
0.9197 High Similarity NPC25768
0.9197 High Similarity NPC95265
0.9197 High Similarity NPC95810
0.9197 High Similarity NPC472570
0.9197 High Similarity NPC70716
0.9197 High Similarity NPC475759
0.9197 High Similarity NPC472573
0.9173 High Similarity NPC472577
0.9173 High Similarity NPC291638
0.9173 High Similarity NPC66761
0.9173 High Similarity NPC195647
0.9173 High Similarity NPC17877
0.913 High Similarity NPC174982
0.913 High Similarity NPC96903
0.913 High Similarity NPC473088
0.913 High Similarity NPC472571
0.913 High Similarity NPC29704
0.913 High Similarity NPC472575
0.913 High Similarity NPC470157
0.913 High Similarity NPC171525
0.913 High Similarity NPC476973
0.913 High Similarity NPC471104
0.913 High Similarity NPC177940
0.913 High Similarity NPC158663
0.913 High Similarity NPC200471
0.913 High Similarity NPC472572
0.913 High Similarity NPC472568
0.913 High Similarity NPC184817
0.913 High Similarity NPC469349
0.913 High Similarity NPC70403
0.913 High Similarity NPC470159
0.9124 High Similarity NPC163087
0.9084 High Similarity NPC147561
0.9044 High Similarity NPC477904
0.9044 High Similarity NPC183270
0.9037 High Similarity NPC283375
0.9037 High Similarity NPC183122
0.9 High Similarity NPC217918
0.9 High Similarity NPC281717
0.8993 High Similarity NPC127857
0.8986 High Similarity NPC477894
0.8971 High Similarity NPC475652
0.8971 High Similarity NPC214550
0.8971 High Similarity NPC210591
0.8963 High Similarity NPC472374
0.8963 High Similarity NPC472372
0.8936 High Similarity NPC301556
0.8936 High Similarity NPC473215
0.8936 High Similarity NPC270590
0.8936 High Similarity NPC471101
0.8936 High Similarity NPC92293
0.8936 High Similarity NPC266265
0.8936 High Similarity NPC476975
0.8929 High Similarity NPC478263
0.8929 High Similarity NPC473602
0.8921 High Similarity NPC34943
0.8913 High Similarity NPC192658
0.8913 High Similarity NPC182869
0.8905 High Similarity NPC48017
0.8905 High Similarity NPC43241
0.8905 High Similarity NPC473758
0.8905 High Similarity NPC473081
0.8905 High Similarity NPC473085
0.8905 High Similarity NPC184747
0.8905 High Similarity NPC473112
0.8905 High Similarity NPC476094
0.8905 High Similarity NPC211137
0.8905 High Similarity NPC200592
0.8905 High Similarity NPC473613
0.8905 High Similarity NPC147880
0.8905 High Similarity NPC473109
0.8905 High Similarity NPC473060
0.8905 High Similarity NPC4341
0.8889 High Similarity NPC477896
0.8889 High Similarity NPC477893
0.8881 High Similarity NPC472548
0.8873 High Similarity NPC470245
0.8873 High Similarity NPC91730
0.8873 High Similarity NPC473214
0.8857 High Similarity NPC92867
0.8857 High Similarity NPC311825
0.8857 High Similarity NPC478264
0.8841 High Similarity NPC266374
0.8832 High Similarity NPC9905
0.8815 High Similarity NPC48929
0.8811 High Similarity NPC51602
0.8811 High Similarity NPC471103
0.8811 High Similarity NPC197037
0.8811 High Similarity NPC470153
0.8811 High Similarity NPC101043
0.8811 High Similarity NPC306799
0.8806 High Similarity NPC238370
0.8803 High Similarity NPC81698
0.8803 High Similarity NPC250046
0.8803 High Similarity NPC60509
0.8794 High Similarity NPC20255
0.8794 High Similarity NPC209592
0.8794 High Similarity NPC48599
0.8794 High Similarity NPC240115
0.8768 High Similarity NPC87934
0.8768 High Similarity NPC162613
0.8759 High Similarity NPC472549
0.875 High Similarity NPC477905
0.8741 High Similarity NPC161239
0.8741 High Similarity NPC476173
0.8741 High Similarity NPC198455
0.8741 High Similarity NPC7095
0.8741 High Similarity NPC112216
0.8741 High Similarity NPC165260
0.8741 High Similarity NPC469448
0.8732 High Similarity NPC132652
0.8732 High Similarity NPC473760
0.8723 High Similarity NPC125882
0.8714 High Similarity NPC177340
0.8714 High Similarity NPC191082
0.8714 High Similarity NPC139067
0.8714 High Similarity NPC246480
0.8714 High Similarity NPC147217
0.8714 High Similarity NPC270498
0.8714 High Similarity NPC473673
0.8714 High Similarity NPC475429
0.8712 High Similarity NPC473220
0.8712 High Similarity NPC470753
0.869 High Similarity NPC229545
0.869 High Similarity NPC219419
0.869 High Similarity NPC248265
0.869 High Similarity NPC11588
0.869 High Similarity NPC134685
0.8681 High Similarity NPC469415
0.8667 High Similarity NPC472394
0.8667 High Similarity NPC80599
0.8662 High Similarity NPC312393
0.8652 High Similarity NPC470231
0.8652 High Similarity NPC51314
0.8652 High Similarity NPC67777
0.8636 High Similarity NPC275576
0.8636 High Similarity NPC470765
0.863 High Similarity NPC34066
0.863 High Similarity NPC155329
0.863 High Similarity NPC473670
0.863 High Similarity NPC473611
0.863 High Similarity NPC114357
0.863 High Similarity NPC473632
0.863 High Similarity NPC132599
0.863 High Similarity NPC469730
0.863 High Similarity NPC21410
0.863 High Similarity NPC469422
0.863 High Similarity NPC282239
0.863 High Similarity NPC259144
0.8613 High Similarity NPC473216
0.8613 High Similarity NPC473399
0.8611 High Similarity NPC222102
0.8611 High Similarity NPC31829
0.8611 High Similarity NPC303429
0.8601 High Similarity NPC327031
0.8593 High Similarity NPC72915
0.8592 High Similarity NPC471100
0.8592 High Similarity NPC471107
0.8582 High Similarity NPC95449
0.8571 High Similarity NPC217091
0.8571 High Similarity NPC169913
0.8571 High Similarity NPC106895
0.8562 High Similarity NPC473414
0.8562 High Similarity NPC1173
0.8562 High Similarity NPC472030
0.8562 High Similarity NPC472022

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472545 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8207 Intermediate Similarity NPD7236 Approved
0.8116 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD7239 Suspended
0.7875 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD8368 Discontinued
0.7727 Intermediate Similarity NPD2629 Approved
0.7703 Intermediate Similarity NPD4628 Phase 3
0.7702 Intermediate Similarity NPD7799 Discontinued
0.7697 Intermediate Similarity NPD8407 Phase 2
0.7669 Intermediate Similarity NPD4198 Discontinued
0.7647 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD7008 Discontinued
0.7605 Intermediate Similarity NPD8434 Phase 2
0.7584 Intermediate Similarity NPD8166 Discontinued
0.7557 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7518 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7741 Discontinued
0.7468 Intermediate Similarity NPD7058 Phase 2
0.7468 Intermediate Similarity NPD7057 Phase 3
0.7467 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7463 Intermediate Similarity NPD5951 Approved
0.7431 Intermediate Similarity NPD3764 Approved
0.7412 Intermediate Similarity NPD8361 Approved
0.7412 Intermediate Similarity NPD8360 Approved
0.7412 Intermediate Similarity NPD8435 Approved
0.7396 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6273 Approved
0.7338 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD7274 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD8127 Discontinued
0.7273 Intermediate Similarity NPD2182 Approved
0.7266 Intermediate Similarity NPD5126 Approved
0.7266 Intermediate Similarity NPD5125 Phase 3
0.7266 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD6599 Discontinued
0.726 Intermediate Similarity NPD7961 Discontinued
0.7233 Intermediate Similarity NPD7819 Suspended
0.7211 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD7075 Discontinued
0.7197 Intermediate Similarity NPD7458 Discontinued
0.7185 Intermediate Similarity NPD6858 Approved
0.7185 Intermediate Similarity NPD7094 Approved
0.7163 Intermediate Similarity NPD6287 Discontinued
0.7162 Intermediate Similarity NPD6355 Discontinued
0.7159 Intermediate Similarity NPD8485 Approved
0.7152 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6663 Approved
0.7135 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD5844 Phase 1
0.7124 Intermediate Similarity NPD3750 Approved
0.7124 Intermediate Similarity NPD7003 Approved
0.7103 Intermediate Similarity NPD5736 Approved
0.7093 Intermediate Similarity NPD8150 Discontinued
0.7089 Intermediate Similarity NPD6591 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD6190 Approved
0.7063 Intermediate Similarity NPD37 Approved
0.7059 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6234 Discontinued
0.7054 Intermediate Similarity NPD1238 Approved
0.7051 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD7610 Discontinued
0.7047 Intermediate Similarity NPD230 Phase 1
0.7039 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4966 Approved
0.7037 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4965 Approved
0.7037 Intermediate Similarity NPD4967 Phase 2
0.7023 Intermediate Similarity NPD1930 Approved
0.7023 Intermediate Similarity NPD1929 Approved
0.7023 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD3748 Approved
0.7013 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD4110 Phase 3
0.7006 Intermediate Similarity NPD7473 Discontinued
0.7 Intermediate Similarity NPD6764 Approved
0.7 Intermediate Similarity NPD6765 Approved
0.7 Intermediate Similarity NPD9545 Approved
0.6987 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6987 Remote Similarity NPD6799 Approved
0.6985 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6981 Remote Similarity NPD5808 Clinical (unspecified phase)
0.697 Remote Similarity NPD164 Approved
0.6963 Remote Similarity NPD2067 Discontinued
0.6957 Remote Similarity NPD6801 Discontinued
0.6943 Remote Similarity NPD2532 Approved
0.6943 Remote Similarity NPD2534 Approved
0.6943 Remote Similarity NPD2533 Approved
0.6937 Remote Similarity NPD4380 Phase 2
0.6933 Remote Similarity NPD7768 Phase 2
0.6928 Remote Similarity NPD6232 Discontinued
0.6928 Remote Similarity NPD2346 Discontinued
0.6928 Remote Similarity NPD5762 Approved
0.6928 Remote Similarity NPD5763 Approved
0.6923 Remote Similarity NPD4806 Approved
0.6923 Remote Similarity NPD4807 Approved
0.6923 Remote Similarity NPD7497 Discontinued
0.6923 Remote Similarity NPD2066 Phase 3
0.6914 Remote Similarity NPD5760 Phase 2
0.6914 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6914 Remote Similarity NPD5761 Phase 2
0.6908 Remote Similarity NPD2799 Discontinued
0.6901 Remote Similarity NPD5305 Approved
0.6901 Remote Similarity NPD5306 Approved
0.6894 Remote Similarity NPD6647 Phase 2
0.6892 Remote Similarity NPD7095 Approved
0.6889 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6884 Remote Similarity NPD6010 Discontinued
0.6883 Remote Similarity NPD970 Clinical (unspecified phase)
0.6871 Remote Similarity NPD3817 Phase 2
0.6864 Remote Similarity NPD7228 Approved
0.6863 Remote Similarity NPD2935 Discontinued
0.6863 Remote Similarity NPD5404 Approved
0.6863 Remote Similarity NPD5408 Approved
0.6863 Remote Similarity NPD5405 Approved
0.6863 Remote Similarity NPD6099 Approved
0.6863 Remote Similarity NPD5406 Approved
0.6863 Remote Similarity NPD2438 Suspended
0.6863 Remote Similarity NPD6100 Approved
0.6855 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6855 Remote Similarity NPD5403 Approved
0.6852 Remote Similarity NPD1934 Approved
0.6846 Remote Similarity NPD6798 Discontinued
0.6846 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5909 Discontinued
0.6839 Remote Similarity NPD6784 Approved
0.6839 Remote Similarity NPD6785 Approved
0.6836 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6835 Remote Similarity NPD5401 Approved
0.6832 Remote Similarity NPD7028 Phase 2
0.6821 Remote Similarity NPD8312 Approved
0.6821 Remote Similarity NPD8313 Approved
0.6818 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6818 Remote Similarity NPD7266 Discontinued
0.6818 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6807 Remote Similarity NPD5494 Approved
0.6802 Remote Similarity NPD7685 Pre-registration
0.6802 Remote Similarity NPD6559 Discontinued
0.68 Remote Similarity NPD8032 Phase 2
0.6797 Remote Similarity NPD4308 Phase 3
0.6792 Remote Similarity NPD7314 Clinical (unspecified phase)
0.679 Remote Similarity NPD7411 Suspended
0.6783 Remote Similarity NPD2932 Approved
0.6781 Remote Similarity NPD1283 Approved
0.677 Remote Similarity NPD3226 Approved
0.6768 Remote Similarity NPD5402 Approved
0.6768 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7199 Phase 2
0.6761 Remote Similarity NPD7009 Phase 2
0.6759 Remote Similarity NPD1608 Approved
0.6755 Remote Similarity NPD4140 Approved
0.6753 Remote Similarity NPD2796 Approved
0.6753 Remote Similarity NPD1551 Phase 2
0.6747 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6741 Remote Similarity NPD6685 Approved
0.6736 Remote Similarity NPD4106 Approved
0.6736 Remote Similarity NPD4135 Approved
0.6736 Remote Similarity NPD4136 Approved
0.6735 Remote Similarity NPD2797 Approved
0.6733 Remote Similarity NPD2313 Discontinued
0.673 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6727 Remote Similarity NPD3882 Suspended
0.672 Remote Similarity NPD8462 Phase 1
0.6716 Remote Similarity NPD1237 Approved
0.6715 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6711 Remote Similarity NPD6832 Phase 2
0.671 Remote Similarity NPD6002 Phase 3
0.671 Remote Similarity NPD6005 Phase 3
0.671 Remote Similarity NPD6006 Clinical (unspecified phase)
0.671 Remote Similarity NPD6003 Clinical (unspecified phase)
0.671 Remote Similarity NPD6004 Phase 3
0.6707 Remote Similarity NPD8455 Phase 2
0.6705 Remote Similarity NPD7240 Approved
0.6689 Remote Similarity NPD7714 Approved
0.6689 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6689 Remote Similarity NPD2798 Approved
0.6689 Remote Similarity NPD6085 Phase 2
0.6689 Remote Similarity NPD7713 Phase 3
0.6689 Remote Similarity NPD6233 Phase 2
0.6689 Remote Similarity NPD7715 Approved
0.6688 Remote Similarity NPD1510 Phase 2
0.6688 Remote Similarity NPD7305 Phase 1
0.6688 Remote Similarity NPD7033 Discontinued
0.6687 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3528 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7115 Discovery
0.6667 Remote Similarity NPD1549 Phase 2
0.6667 Remote Similarity NPD3818 Discontinued
0.6667 Remote Similarity NPD3019 Approved
0.6667 Remote Similarity NPD3455 Phase 2
0.6667 Remote Similarity NPD7798 Approved
0.6667 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5048 Discontinued
0.6667 Remote Similarity NPD5667 Approved
0.6645 Remote Similarity NPD4307 Phase 2
0.6645 Remote Similarity NPD4060 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data